{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:34:28Z","timestamp":1793313268942,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaci.2026.09.004","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:22:41Z","timestamp":1789665761000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allergen mRNA therapy for house dust mite allergy"],"prefix":"10.1016","author":[{"given":"Mia A.","family":"Natale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yrina","family":"Rochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilian R.","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9790-6332","authenticated-orcid":false,"given":"Marc E.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.09.004_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molimm.2023.02.004","article-title":"Current advances in house dust mite allergen immunotherapy (AIT): routes of administration, biomarkers and molecular allergen profiling","volume":"155","author":"Batard","year":"2023","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2026.09.004_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3345\/cep.2022.00479","article-title":"New approaches to immunotherapy in house dust mite allergy","volume":"66","author":"Kim","year":"2023","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.jaci.2026.09.004_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jaip.2015.06.019","article-title":"House dust mite respiratory allergy: an overview of current therapeutic strategies","volume":"3","author":"Calderon","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.09.004_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/pai.70401","article-title":"Involution of IgE sensitization to house dust mite allergen molecules by age","volume":"37","author":"Semedo","year":"2026","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.09.004_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/all.15553","article-title":"Specific IgE against the house dust mite allergens Der p 5, 20 and 21 influences the phenotype and severity of atopic diseases","volume":"78","author":"Walsemann","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.09.004_bib6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"mRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.09.004_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194080","article-title":"Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice","volume":"135","author":"Rochman","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.09.004_bib8","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jaci.2026.05.023","article-title":"Antigen-specific messenger RNA lipid nanoparticle therapy with mTOR inhibition promotes regulatory T cells and limits allergy","volume":"158","author":"Rochman","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.09.004_bib9","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/all.16049","article-title":"Immunotherapeutic effects of specific and nonspecific mRNA-lipid nanoparticles in a mouse model of HDM-induced airway inflammation","volume":"79","author":"Thanasarnthungcharoen","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.09.004_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/all.15527","article-title":"Nucleoside-modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergens","volume":"78","author":"Jitthamstaporn","year":"2023","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492600638X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492600638X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:25:42Z","timestamp":1793312742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492600638X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"alternative-id":["S009167492600638X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.09.004","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergen mRNA therapy for house dust mite allergy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}